RE:Gud... Thanks for sharing your insights MUGMODs.
Two questions based on your statement:
1) "very unusual and lucky outcome in the high valued sale of Paladin shares" What was the cause of the unusual lucky outcome?
Was it a time when pharma buyouts where happening like crazy, a certain tax advantage or benefit? what was the reason Paladin was sold? only for Goodman to start again, why didn't he keep Paladin?
2) "This time around, I won't be betting a sale of the company but a dividend to follow many ... many ... many years out."
Has Goodman issued dividends with Paladin before? What are your thoughts and reason for Goodman issuing dividend in the future? I remember in an interview with Jason Donville, he said Paladin was a great company but had too much cash and didn't know what to do with it. Perhaps it's different this time and Goodman is trying to create something like Johnson and Johnson for his family and shareholders?
Thanks for your time,
Dan
---
RE:Gud...
I will go back to my comments early in Knight's start-up days...and I will add a little to it...
I expect it to be similar to my experiences with Paladin, when Paladin was trading at $5/share.
It was a long wait with fluctuations between $5 and $8 per share.
Analysts never really talked about Paladin until it got to $40-$45 a share...as I recall.
This time, analysts are talking about Knight but only because of a very unusual and lucky outcome in the high valued sale of Paladin shares.
The two constants with both companies...is (I think) ... Goodman's patience and other's inability to read his moves. His goal to find value and he will sit in his little boat ... fishing line out ... and troll his way to value.
With Knight ... I expect nothing different than the first time ... except that Goodman may be a little more excited to better Paladin's efforts.
This time around, I won't be betting a sale of the company but a dividend to follow many ... many ... many years out.
Good Luck!